Healthcare -
Biotechnology - NASDAQ - US
$ 1.61
-3.01 %
$ 60.2 M
Market Cap
-1.38
P/E
Price Target
Average
521.12%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
--2.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
PDS Biotechnology Corporation
Wall Street analysts predict an average 1-year price target for PDSB of $10 , with forecasts ranging from
a
low of
$9 to a high of $11 .
PDSB Lowest Price Target
Wall Street Target
9 USD
459.01%
PDSB Average Price Target
Wall Street Target
10 USD
521.12%
PDSB Highest Price Target
Wall Street Target
11 USD
583.23%
REVENUE FORECAST
Revenue Forecast Chart PDSB
EBIT FORECAST
EBIT Forecast Chart PDSB
NET INCOME FORECAST
Net Income Chart PDSB